Search
Sulamserod
go.drugbank.com/drugs/DB20179ExperimentalSulamserod is a small molecule drug. The usage of the INN stem '-serod' in the name indicates that Sulamserod is a serotonin receptor antagonist and partial agonist.
Tinazoline
go.drugbank.com/drugs/DB20310ExperimentalTinazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Tinazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Sipatrigine
go.drugbank.com/drugs/DB21032ExperimentalSipatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Sipatrigine is a sodium channel blocker, signal transduction modulator.
Nemazoline
go.drugbank.com/drugs/DB21115ExperimentalNemazoline is a small molecule drug. The usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Ebrotidine
go.drugbank.com/drugs/DB21220ExperimentalEbrotidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Ebrotidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Aloracetam
go.drugbank.com/drugs/DB21233ExperimentalAloracetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Aloracetam is a piracetam type amide type nootrope agent.
Oxmetidine
go.drugbank.com/drugs/DB21430ExperimentalOxmetidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Oxmetidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Tisolagiline
go.drugbank.com/drugs/DB21655ExperimentalTisolagiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Tisolagiline is a monoamine oxydase (MAO)-inhibitor type B.
Mosperafenib
go.drugbank.com/drugs/DB21673ExperimentalMosperafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Mosperafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
Abivertinib
go.drugbank.com/drugs/DB15327InvestigationalThe study is expected to be completed in March 2021.[L17398] … [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies.